| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |